Veteran owned small business Spartan Medical Inc revealed on Wednesday that it plans to introduce Altapure LLC's AP-4 High-level Disinfection-System (HLDS) across the US market in the fight against COVID-19.
This critically needed, AP-4 advanced-ultrasonic-technology ensures that all healthcare and long-term care facilities, schools, universities, cruise lines, among others, can provide the cleanest/safest environment to fellow Americans. Altapure's first fully integrated high-level disinfection system AP–4 Medical HLD System will eliminate all bacteria, spores and viruses in a treated space. The system is easily operated by one person and many facilities have one person running two to three machines at a time.
The AP–4 is a single mobile unit platform, containing a combined submicron aerosol output device and environmental air re-processor system with data feedback. The process's agent is organic, biodegradable, food safe and leaves zero residue. Its PAA agent is an EPA registered cold sterilant, bactericide, fungicide, virucide and sporicide. In short, there has not yet been a pathogen that can survive the disinfection cycle, making the implementation of this state-of-the-art solution paramount during COVID-19 and beyond.
In collaboration with NASA, Altapure has shown efficacy in the sterilization of PPE with the 'peracetic acid technology.
Laronix and Greater Baltimore Medical Center launch Laronix MIRA Voice investigational study
BD receives CE Mark for Revello vascular covered stent
GAIA and Daiichi Sankyo Europe partner on digital therapeutic for cardiovascular care
Airiver Medical's Airiver Pulmonary DCB receives US FDA Breakthrough Device Designation
BD receives FDA clearance for Surgiphor 1000mL irrigation system
Galderma secures EU, US and Canada approval for new Restylane syringe
Organon licenses MIUDELLA IUD from Sebela Pharmaceuticals
Advita Ortho updates Chime clinical exchange application
Philips launches InkSpace Imaging Snuggle coil for 3.0T MRI systems
Realheart secures European patent for artificial heart technology
Median Technologies secures FDA clearance for AI lung cancer screening software
Eli Lilly to invest over USD3.5bn in new Pennsylvania plant
Spine Innovation's LOGIC Titanium Implant System receives US FDA 510(k) market approval
Apiject to open new generic injectable drug manufacturing facility in Apex, NC
Zylox-Tonbridge agrees staged acquisition of Germany's Optimed